VU6015929 is a potent, selective and orally active dual discoidin domain receptor 1/2 (DDR1/2) inhibitor with IC50 values of 4.67 nM and 7.39 nM, respectively and potently blocks collagen-induced DDR1 activation and collagen-IV production.

DDR1-IN-1 is a potent and selective DDR1 receptor tyrosine kinase inhibitor with IC50/EC50 of 105 nM/87 nM and 4-fold less potent for DDR2 (IC50= 413 nM).

DDR1-IN-2 is an inhibitor of discoidin domain receptor 1 (DDR1) with IC50 of 13.1 nM, the IC50 of DDR2 is 203 nM.

FGFR1/DDR2 inhibitor 1是一种双重靶向FGFR1和DDR2的抑制剂，展现了抗肿瘤活性，对多种肿瘤研究具有潜力。

ODM-203 is a selective inhibitor of FGFR and VEGFR with IC50 values of 11, 16, 6, 35nM for recombinant FGFR1-4 and 26, 9, 5nM for VEGFR1-3, respectively.

BAY-826 is a selective and potent TIE-2 inhibitor with Kdof 1.6 nM, respectively.

LY2801653 2HCl is a potent, orally bioavailable, small-molecule inhibitor of c-MET kinase (Ki= 2 nM).

DDR1-IN-5 is a selective Discoidin Domain Receptor family, member 1 (DDR1) inhibitor with an IC50 of 7.36 nM. DDR1-IN-5 inhibits auto-phosphorylation DDR1b (Y513) with an IC50 of 4.1 nM. DDR1-IN-5 has anti-cancer activity[1].

DDR1-IN-6 is a selective Discoidin Domain Receptor family, member 1 (DDR1) inhibitor with an IC50 of 9.72 nM. DDR1-IN-6 inhibits auto-phosphorylation DDR1b (Y513) with an IC50 of 9.7 nM. DDR1-IN-6 has anti-cancer activity[1].

WRG-28 is a selective allosteric inhibitor of DDR2 with IC50 of 230 nM.

DDR Inhibitor is a potent discoidin domain receptor (DDR) inhibitor, with an IC50 of 3.3 nM for DDR2, and shows 53% inhibition on DDR1 at 1.5 nM.

ML 786 2HCl is a potent Raf kinase inhibitor with IC50s of 2.1, 2.5 and 4.2 nM for B-RafV600E, C-Raf and wild-type B-Raf, respectively.